Phone: +41 44 633 74 01
Born in Rome (Italy) on 1 May 1963, Dario Neri studied Chemistry at the Scuola Normale Superiore of Pisa, graduating with a thesis on the synthesis and characterization of complex polyunsaturated secondary metabolites, isolated from higher plants. He earned his doctorate in chemistry under Professor Kurt Wüthrich in the Institute of Molecular Biology and Biophysics at the ETH Hönggerberg in 1992. His dissertation was awarded the ETH Zurich silver medal. With an EU Bridge Bursary, he spent four years at the Cambridge Centre for Protein Engineering, Medical Research Council, where he worked under the supervision of Sir Gregory Winter. He has now been a Professor at the ETH Zurich since 1996. The research of the group Neri focuses on the engineering of therapeutic antibodies for the therapy of cancer and other angiogenesis-related disorders. Other research activities include the chemical proteomic discovery of novel vascular markers of pathology and the development of DNA-encoded chemical libraries. Dario Neri is a co-founder of Philogen (www.philogen.com) and Philochem (www.philochem.com). These companies have brought seven antibody-based products into multicenter clinical trials in patients with cancer.
Dario Neri has published over 160 articles in peer-reviewed scientific journals. He is the recipient of the ISOBM Abbott Prize 2000, of the Amgen-Dompe’ Biotec Award 2000, of the Mangia d’Oro 2001, of the Prous Award 2006 of the European Federation of Medicinal Chemistry, of the Robert-Wenner-Prize 2007 of the Swiss Cancer League and of the SWISS BRIDGE Award 2008.
Diese Website wird in älteren Versionen von Netscape ohne graphische Elemente dargestellt. Die Funktionalität der Website ist aber trotzdem gewährleistet. Wenn Sie diese Website regelmässig benutzen, empfehlen wir Ihnen, auf Ihrem Computer einen aktuellen Browser zu installieren. Weitere Informationen finden Sie auf
The content in this site is accessible to any browser or Internet device, however, some graphics will display correctly only in the newer versions of Netscape. To get the most out of our site we suggest you upgrade to a newer browser.